Global Prevalence and Future of Diabetes Mellitus
- 54 Citations
- 12k Downloads
Abstract
This chapter addresses the prevalence of diabetes mellitus (DM) in various countries according to geographic regions, as designated in an atlas published by the International Diabetes Federation in 2011.1 These include countries and territories in Europe, Africa, Middle East, North Africa, North America and Caribbean islands, South and Central America, South-East Asia and the Western Pacific Islands. Actual prevalence of DM (cases per 100 population) is expressed not only specifically for each individual country (national value) but more importantly, corrected by the population, age structure (comparative value) and also as an estimate of DM trend in 2030. It can be seen that in all countries (Tables 1–5) the prevalence of DM is on rise. A substantial contributing factor to the rise is the steady increase in body weight and obesity in many parts of the world. Economic stability and technological progress promote obesity in European countries, the USA and in oil producing countries such as Saudi Arabia, United Arab Emirates and Kuwait. Also environmental factors, social trends toward higher energy intake and reduced energy expenditure also have a decisive role to play in the pathogenesis of overweight and DM.
Keywords
Saudi Arabia Middle East International Diabetes Federation Global Prevalence Caribbean IslandPreview
Unable to display preview. Download preview PDF.
References
- 1.IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 2011.Google Scholar
- 2.Ginter E, Simko V. Diabetestype 2 pandemic in 21st century. Bratisl Med J 2010; 111:134–137.Google Scholar
- 3.Ahmed O, Boschi-Pinto C, Lopez AD et al. Age standardization of rates: a new WHO standard. Geneva, World health organization 2001.Google Scholar
- 4.Harris R, Donahue K, Rathore SS et al. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services task force. ann Intern Med 2003; 138:215–229.CrossRefPubMedGoogle Scholar
- 5.Ginter E, Simko V. adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk. Bratisl Med J 2008; 109:224–230.Google Scholar
- 6.Mokad AH, Ford ES, Bouman BA et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003; 289:76–79.CrossRefGoogle Scholar
- 7.Hossain P, Kawar B, Nahas ME et al. Obesity and diabetes in the developing word—a growing challenge. N Engl J Med 2007; 356:213–215.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Morrish NJ, Wang SL, Stevens LK et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl. 2):S14–S21.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Roglic G, Unwin N, Bennet PH et al. the burden of mortality attributable to diabetes. Diabetes care 2005; 28:2130–2135.CrossRefPubMedGoogle Scholar
- 10.Narayan V, Boyle JP, Geiss LS et al. Impact of recent increase in incidence on future diabetes burden U.S., 2005–2050. Diabetes care 2006; 29:2114–2116.CrossRefPubMedGoogle Scholar
- 11.Chiefari E, Tanyolaç S, Paonessa F et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 2011; 305sn9):903–912.CrossRefPubMedGoogle Scholar
- 12.McCarthy MI. Genomics, type 2 diabetes and obesity. N Engl J Med 2010; 363:2339–2350.CrossRefPubMedGoogle Scholar